RECORD // Company

Maxcyte, Inc.

Formerly: MAXCYTE INC

Built 2026-11-21T11:35:37Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (2 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

Gleif lei (1)
  • MAXCYTE, INC. · legal entity in this company's GLEIF ownership tree (LEI 54930053YHXULRFCU991)
SEC EDGAR (1)
Matched by name only, not merged (2)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

  • MaxCyte, Inc. · Ctgov · same registered legal name as 'MAXCYTE, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • MAXCYTE, INC. · USAspending · same registered legal name as 'MAXCYTE, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare

4 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-10 · accession 0001104659-26-125236

ItemValuePeriodFormFiledAccessionReport
Revenue$10,152,0003 months ended 2026-09-3010-Q2026-11-100001104659-26-1252362026-11-21 11:35 UTCReport an error
Net income (loss)$-4,762,0003 months ended 2026-09-3010-Q2026-11-100001104659-26-1252362026-11-21 11:35 UTCReport an error
Cash and cash equivalents$13,372,000at 2026-09-3010-Q2026-11-100001104659-26-1252362026-11-21 11:35 UTCReport an error
Contract liabilities (total)$7,699,000at 2026-09-3010-Q2026-11-100001104659-26-1252362026-11-21 11:35 UTCReport an error

Negative as reported in the filing.

Not in this report's XBRL: Interest expense.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001287098
Ticker
MXCT
EIN
522210438
CUSIP
57777K106
Record ID
sx:sec:0001287098

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

45 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-18SEC EDGAR company profile2026-11-21 11:35 UTCReport an error
SIC industry8731 Services-Commercial Physical & Biological Research2026-11-18SEC EDGAR company profile2026-11-21 11:35 UTCReport an error
State of incorporationDE2026-11-18SEC EDGAR company profile2026-11-21 11:35 UTCReport an error
Fiscal year end (MMDD)12312026-11-18SEC EDGAR company profile2026-11-21 11:35 UTCReport an error
Business address9713 KEY WEST AVENUE,, SUITE 400, ROCKVILLE, MD, 208502026-11-18SEC EDGAR company profile2026-11-21 11:35 UTCReport an error
ExchangesNasdaq2026-11-18SEC EDGAR company profile2026-11-21 11:35 UTCReport an error
Revenue (fiscal year ended 2025-12-31)$33,026,0002025-12-3110-K, XBRL Revenues2026-11-21 11:35 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)$-44,630,0002025-12-3110-K, XBRL NetIncomeLoss2026-11-21 11:35 UTCReport an error
Total assets (at 2025-12-31)$202,507,0002025-12-3110-K, XBRL Assets2026-11-21 11:35 UTCReport an error
Stockholders' equity (at 2025-12-31)$171,490,0002025-12-3110-K, XBRL StockholdersEquity2026-11-21 11:35 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$20,065,0002025-12-3110-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-21 11:35 UTCReport an error
Operating cash flow (fiscal year ended 2025-12-31)$-34,410,0002025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-21 11:35 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31)$1,768,0002025-12-3110-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment2026-11-21 11:35 UTCReport an error
Remaining performance obligation (at 2025-12-31)$367,0002025-12-3110-K, XBRL RevenueRemainingPerformanceObligation2026-11-21 11:35 UTCReport an error
Operating lease liabilities (at 2025-12-31)$17,943,0002025-12-3110-K, XBRL OperatingLeaseLiability2026-11-21 11:35 UTCReport an error
Form D total offering amount (D filed 2016-09-29)$760,3082016-09-29D2026-11-21 11:35 UTCReport an error
Form D total amount sold (D filed 2016-09-29)$760,3082016-09-29D2026-11-21 11:35 UTCReport an error
Form D industry groupBiotechnology2016-09-29D2026-11-21 11:35 UTCReport an error
Form D revenue range$5,000,001 - $25,000,0002016-09-29D2026-11-21 11:35 UTCReport an error
Form D date of first sale2016-03-292016-09-29D2026-11-21 11:35 UTCReport an error
8-K Item 1.01, Entry into a Material Definitive (filed 2026-11-10)Agreement. On November 9, 2026, MaxCyte, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with Ohio TopCo LP and Arcline Capital Partners A LP (together, the “Sellers”), affiliates of Arcline Investment Management, and the other parties thereto, pursuant to which the Company will acquire, indirectly, all of the outstanding equity interests of Akron BioProducts LLC (“Akron”) (the “Acquisition”). The consideration for the Acquisition consists of (i) $105.0 million in cash payable at the closing of the Acquisition (the “Closing”), subject to customary adjustments, (ii) 20,639,733 shares (the “Stock Consideration”) of the Company’s common stock, par…2026-11-10SEC EDGAR 8-K 0001104659-26-124829 (text as filed, excerpt)2026-11-21 11:35 UTCReport an error
8-K Item 2.02, Results of Operations and Financial (filed 2026-11-10)Condition. On November 10, 2026, the Company issued a press release announcing its financial results for the quarter ended September 30, 2026. A copy of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this Item 2.02, including Exhibit 99.1 hereto, is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information contained herein and in the accompanying exhibit is not incorporated by reference in any filing of the Company under the Securities Act of…2026-11-10SEC EDGAR 8-K 0001104659-26-124829 (text as filed, excerpt)2026-11-21 11:35 UTCReport an error
8-K Item 3.02, Unregistered Sales of Equity Securities (filed 2026-11-10)The information set forth in Item 1.01 of this Current Report on Form 8-K regarding the Stock Consideration is incorporated herein by reference. The 20,639,733 shares of Common Stock comprising the Stock Consideration will be issued to the Sellers at the Closing in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act, based in part on the Sellers’ representations that each is an “accredited investor” (as defined in Rule 501(a) of Regulation D) acquiring the shares for investment.2026-11-10SEC EDGAR 8-K 0001104659-26-124829 (text as filed, excerpt)2026-11-21 11:35 UTCReport an error
8-K Item 7.01, Regulation FD Disclosure (filed 2026-11-10)On November 10, 2026, the Company issued a press release announcing the Acquisition, a copy of which is furnished as Exhibit 99.2 to this Current Report on Form 8-K. A copy of the investor presentation regarding the Acquisition is furnished as Exhibit 99.3 to this Current Report on Form 8-K. A copy of the Company’s corporate presentation is furnished as Exhibit 99.4 to this Current Report on Form 8-K. The information in this Item 7.01, including Exhibit 99.2, Exhibit 99.3 and Exhibit 99.4 hereto, is furnished and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, and shall not be incorporated by reference in…2026-11-10SEC EDGAR 8-K 0001104659-26-124829 (text as filed, excerpt)2026-11-21 11:35 UTCReport an error
8-K Item 2.02, Results of Operations and Financial (filed 2026-10-14)Condition. On October 14, 2026, MaxCyte, Inc. (the “Company”) issued a press release announcing certain preliminary, unaudited revenue results for the three months ended September 30, 2026, and increasing its full-year 2026 revenue guidance. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The preliminary revenue results disclosed in Exhibit 99.1 are unaudited and based on management’s estimates and information available to the Company as of the date of the press release. These results remain subject to completion of the Company’s quarter-end closing procedures and review of its interim financial statements.…2026-10-14SEC EDGAR 8-K 0001104659-26-115745 (text as filed, excerpt)2026-11-21 11:35 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-08-12)On August 12, 2026, MaxCyte, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended June 30, 2026. A copy of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this Current Report on Form 8-K, including Exhibit 99.1 hereto, is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section. The information contained herein and in the accompanying exhibit is not incorporated by reference in any filing of the Company under the…2026-08-12SEC EDGAR 8-K 0001104659-26-094886 (text as filed, excerpt)2026-11-21 11:35 UTCReport an error
8-K Item 7.01, Regulation FD Disclosure (filed 2026-08-12)On August 12, 2026, the Company posted an updated corporate presentation, which the Company may use from time to time in communications or conferences, to its website at https://investors.maxcyte.com. A copy of the corporate presentation is furnished as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this Current Report on Form 8-K, including Exhibit 99.2 hereto, is furnished and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section. The information contained herein and in the accompanying exhibit is not incorporated by reference in any filing of the…2026-08-12SEC EDGAR 8-K 0001104659-26-094886 (text as filed, excerpt)2026-11-21 11:35 UTCReport an error
Employer name (as filed)MaxCyte Inc.2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-21 11:35 UTCReport an error
Certified LCAs12026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-21 11:35 UTCReport an error
Certified LCAs later withdrawn02026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-21 11:35 UTCReport an error
Total worker positions on certified LCAs12026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-21 11:35 UTCReport an error
Top job titles (title, LCA count)Senior Electrical Engineer (1)2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-21 11:35 UTCReport an error
Wage offered, annualized (n, min, median, max)median $117,552 (range $117,552-$117,552, 1 filings)2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-21 11:35 UTCReport an error
Worksite statesMD2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-21 11:35 UTCReport an error
Plan (pension, plan no. 001)MAXCYTE, INC. 401(K) PLAN: 157 participants, assets $24,638,4802025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-21 11:35 UTCReport an error
Largest institutional holder #1 (13F as filed): Capricorn Fund Managers Ltd$10,086,0002026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:35 UTCReport an error
Largest institutional holder #2 (13F as filed): Vitruvian Partners LLP$6,203,3282026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:35 UTCReport an error
Largest institutional holder #3 (13F as filed): VANGUARD CAPITAL MANAGEMENT LLC$4,958,4792026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:35 UTCReport an error
Largest institutional holder #4 (13F as filed): Mudita Advisors LLP$4,145,9472026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:35 UTCReport an error
Largest institutional holder #5 (13F as filed): BlackRock, Inc.$3,764,9812026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:35 UTCReport an error
Largest institutional holder #6 (13F as filed): Brooklands Fund Management Ltd$3,674,0272026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:35 UTCReport an error
Largest institutional holder #7 (13F as filed): BNP PARIBAS ASSET MANAGEMENT Holding S.A.$3,411,4712026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:35 UTCReport an error
Largest institutional holder #8 (13F as filed): CADIAN CAPITAL MANAGEMENT, LP$2,707,4342026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:35 UTCReport an error
Largest institutional holder #9 (13F as filed): Peapod Lane Capital LLC$2,614,6752026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:35 UTCReport an error
Largest institutional holder #10 (13F as filed): RENAISSANCE TECHNOLOGIES LLC$2,350,2842026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:35 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.